Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.
If you're worried you missed the boat on Eli Lilly, you shouldn't be, as there are other healthcare companies involved in the ...
Major employers and insurance companies are eliminating coverage for GLP-1 weight-loss drugs. Louisiana families now must ...
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
Negotiated prices for Kisqali and Verzenio, which the agency said cost Medicare over $1 billion in a year, would become effective starting 2028.
CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...
The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling drugs - though there were few surprises. The Centers for Medicare and ...
The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...
The FDA paused trials for two experimental gene therapies from Regenxbio after one child developed a brain tumor, the company ...
The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly’s top-selling ...
The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling ...
Axios on MSN
Medicare selects GLP-1, Botox for negotiations
Medicare wants to negotiate lower prices for Eli Lilly's GLP-1 drug Trulicity and AbbVie's Botox in its next round of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results